Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of ISOFOL MEDICAL AB
No Price
Closing Price XSTO 28.04.2026:
0,68 SEK
28.04.2026 15:29
Current Prices from ISOFOL MEDICAL AB
Exchange
Ticker
Currency
Last Trade
Price
Daily Change
NASDAQ STOCKHOLM AB
ISOFOL.ST
SEK
28.04.2026 15:29
0,68 SEK
-0,03 SEK
-4,12 %
Share Float & Liquidity
Free Float71,19 %
Shares Float200,11 M
Shares Outstanding281,11 M
Company Profile for ISOFOL MEDICAL AB Share
Isofol Medical AB (publ), a clinical stage biotech company, develops, commercializes, and sells oncology drugs in Sweden and internationally. The company develops arfolitixorin, which is in phase 3 clinical trial for the treatment of advanced colorectal cancer. It has strategic collaborations with Recipharm, Merck & Cie, and Sahlgrenska University Hospital. The company was incorporated in 2008 and is headquartered in Gothenburg, Sweden.
